Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation

Chinese Medical Journal

Volumn 121, Issue 18, 2008, Pages 1770-1774

  You, Yong ^a   Li, Qiu Bai ^a   Chen, Zhi Chao ^a   Li, Wei Ming ^a   Xia, Ling Hui ^a   Zhou, Hao ^a   Zou, Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Acute leukaemia; Allogeneic haematopoietic stem cell transplantation; Fludarabine; Relapse

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; FLUDARABINE; HYDROXYUREA; MERCAPTOPURINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; THALIDOMIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DNA SEQUENCE; DONOR LYMPHOCYTE INFUSION; DONOR STEM CELL INFUSION; FEMALE; GRAFT VERSUS HOST REACTION; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNOTHERAPY; LEUKEMIA RELAPSE; LOW DRUG DOSE; LUNG MYCOSIS; MALE; MORTALITY; NEUTROPHIL; SURVIVAL RATE; THROMBOCYTE; WHOLE BODY RADIATION;

EID: 54349101336     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200809020-00003     Document Type: Article

References (22)

1. Mortimer J, Blinder MA, Schulman S, Appelbaum FR, Buckner CD, Clift RA, et al. Relapse of acute leukemia after marrow transplantation: Nature history and results of subsequent therapy. J Clin Oncol 1989; 7: 50-57.
2. Frassoni F, Barrett AJ, Grañena A, Ernst P, Garthon G, Kolb HJ, et al. Relapse after allogeneic bone marrow transplantation for acute leukemia: a survey by the EBMT of 117 cases. Br J Haematol 1988; 70: 317-320.
3. Barrios M, Jiménez-Velasco A, Román-Gómez J, Madrigal ME, Castillejo JA, Torres A, et al. Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia. Haematologica 2003; 88: 801-810.
4. Michallet M, Tanguy ML, Socié G, Thiébaut A, Belhabri A, Milpied N, et al. Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukemias for patients, who underwent a first allogeneic bone marrow transplantation: A survey of the Société Française de Greffe de Moelle (SFGM). Br J Haematol 2000; 108: 400-407.
5. Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W. Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/ haploidentical T-cell-replete hematopoietic stem cell transplantation. Haematologica 2007; 92: 414-417.
6. Cheson BD, Bennett JM, Kopecky KJ, Büchner T, Willman CL, Estey EH, et al. Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol 2003; 21: 4642-4649.
7. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A, Niederwieser D, Joint Accreditation, et al. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow transplant 2007; 39: 71-87.
8. Platzbecker U, Binder M, Schmid C, Rutt C, Ehninger G, Bornhäuser M. Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantation. Haematologica 2008; 93: 1276-1278.
9. Kikushige Y, Takase K, Sata K, Aoki K, Numata A, Miyamoto T, et al. Repeated relapses of acute myelogenous leukemia in the isolated extramedullary sites following allogeneic bone marrow transplantations. Intern Med 2007; 46: 1011-1014.
10. Fukushima T, Miyazaki Y, Honda S, Kawano F, Moriuchi Y, Masuda M, et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia 2005; 19: 829-834.
11. Barrett AJ, Locatelli F, Treleaven JG, Gratwohl A, Szydło R, Zwaan FE. Second transplants for leukemic relapse after bone marrow transplantation: high early mortality but favorable effect of chronic GVHD on continued remission. Br J Haematol 1991; 79: 567-574.
12. Barrett AJ, Locatelli F, Treleaven JG, Gratwohl A, Szydło R, Zwaan FE. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant 1992; 9: 269-275.
13. Radich JP, Sanders JE, Buckner CD, Martin PJ, Petersen FB, Bensinger W, et al. Second allogeneic bone marrow transplantation for patients with recurrent leukemia after initial transplant with total-body-irradiation-containing regimens. J Clin Oncol 1993; 11: 304-313.
14. Kishi K, Takahashi S, Gondo H, Shiobara S, Kanamaru A, Kato S, et al. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes. Bone Marrow Transplant 1997; 19: 461-466.
15. Bosi A, Bacci S, Miniero R, Locatelli F, Laszlo D, Longo G, et al. Second allogeneic bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Leukemia 1997; 11: 420-424.
16. Mehta J, Powles R, Treleaven J, Horton C, Meller S, Pinkerton CR, et al. Outcome of acute leukemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplant 1997; 19: 709-719.
17. Nagler A, Or R, Naparstek E, Varadi G, Slavin S. Second allogeneic stem cell transplantation using non-myeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantation. Exp Hematol 2000; 28: 1096-1104.
18. Dazzi F, Szydlo RM, Craddock C, Cross NC, Kaeda J, Chase A, et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia. Blood 2000; 95: 67-71.
19. Shimoni A, Hardan I, Shem-Tov N, Rand A, Yerushalmi R, Nagler A. fludarabinearabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes. Leuk Lymphoma 2007; 48: 2352-2359.
20. Xu LP, Zhang HY, Huang XJ, Liu KY, Liu DH, Han W, et al. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease. Chin Med J 2007; 120: 1666-1671.
21. Lion T, Daxberger H, Dubovsky J, Filipcik P, Fritsch G, Printz D, et al. Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation. Leukemia 2001; 15: 307-310.
22. Turkiewicz D, Gorczynska E, Toporski J, Kalwak K, Rybka B, Noworolska D, et al. Monitoring of hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation by dual-color FISH analysis of X and Y chromosomes. Leuk Res 2003; 27: 993-998.